X-trodes and the EIC Accelerator: Sleep Tests on a Skin Patch
X-trodes, based in Herzliya, Israel, makes Smart Skin, thin dry printed electrode patches with a small wireless recorder that capture brain waves, eye movements, muscle and heart signals outside the clinic, based on a decade of research in Professor Yael Hanein's neuro-engineering laboratory. It was selected in the EIC Accelerator's March 2023 cut-off with blended finance and received an EU grant of €2.46 million for S-trodes, a €3.67 million project that ran from November 2023 to January 2026, according to CORDIS. The aim was a medical-grade sleep test people can use at home, to replace overnight polysomnography in sleep laboratories, with the clinical validation needed for use in Europe.
The only periodic report published on CORDIS, covering the first period to October 2024, says X-trodes redesigned its recorder and patches for sleep, produced and verified a first batch, developed algorithms to detect sleep spindles and REM sleep without atonia, and made "significant progress" on automatic sleep scoring, expected to be completed in 2025, according to the CORDIS reporting page. It said preliminary tests indicated "a possibility to perform the CE submission ahead of time". Sources reviewed on 7 November 2026 do not show a CE mark, validation results or a launch of the sleep system. A CORDIS Results in Brief article, updated in June 2026, describes the product as aimed at European regulatory approval but gives no study results or regulatory status.
Company file
- Legal entity
- X-trodes Ltd, Herzliya, Israel
- CEO
- Dr Ziv Peremen
- CTO
- Prof. Yael Hanein
- Product
- Smart Skin patches, X-trodes System M
- US status
- FDA 510(k) K232210, February 2024
- Advisers named
- Prof. Thomas Penzel, Prof. Dieter Riemann
- EIC funding
- €2.5M grant plus €2.7M equity announced, 2023
Where X-trodes Stands Now
The US Food and Drug Administration cleared X-trodes System M in February 2024 for electrophysiological monitoring in healthcare and home settings, according to the FDA 510(k) database, and the company said it would pursue further validation "with an initial focus on the cardiovascular and sleep monitoring markets", according to PR Newswire. Its website offers its systems to researchers and lists recent posts on facial muscle sensing for human-machine interfaces, a different market. Its newest blog archive entries date from September 2025. Revenue figures are not public.
The record
From a university patch to a home sleep test
X-trodes won FDA clearance for its general monitoring system early in the EIC project. The sleep-specific validation and CE submission the project funded have not been reported.
- Jan 2023Accuracy study57 participants, sponsor B-Cube
- Mar 2023EIC Accelerator cut-offS-trodesblended finance
- Nov 2023Project starts€2.46M EU grant
- Feb 2024FDA clearanceX-trodes System M, K232210
- Oct 2024First period endsNew sleep patches verified
- Jan 2026Project endsNo final periodic report public
FDA 510(k) database, ClinicalTrials.gov, CORDIS and PR Newswire.
"Clinical Data collection and Preliminary laboratory tests have been performed, and the X-trodes Sleep System passed the tests successfully, indicating a possibility to perform the CE submission ahead of time."
X-trodes, first periodic report to the EICThe Technology: A Sleep Lab You Wear
A polysomnography test means a night in a sleep laboratory wired to sensors, which the report calls costly, hard to access and an unnatural sleep environment. X-trodes' patches stick to the face and body, record the same kinds of signals, and send them to the cloud for analysis. The report says sleep disorders affect a third of the world's population and are often undiagnosed. A home test must match the lab's accuracy to replace it, and that comparison for the sleep system has not been published.
The reporting gap
Project months against months covered by public reports
The only public report covers the first 12 of the project's 27 months. The clinical validation and CE submission were due in the remaining period.
CORDIS, project 190162340. Months.
What the EIC Award Promised, and What the Record Shows
The award promised to optimise the platform and carry out the clinical validation needed for a CE-marked home sleep test. The first year delivered hardware and algorithms. The validation, the auto-scoring software and the CE submission were due later; none is on public record in the sources reviewed, and no final periodic report is public.
- Sleep hardware redesignDeliveredFirst batch verified.
- Sleep algorithmsPartialAuto-scoring unfinished, 2024.
- Clinical validationUnverifiedNo results published.
- CE markNot announcedNone found.
The Money
The EU contribution covered 67% of the project's recorded costs. X-trodes announced in June 2023 that it had been selected for a €5.2M EIC award, a €2.5M grant plus a €2.7M equity investment, according to its press release; sources reviewed do not show whether the equity investment closed. Earlier, the company announced a $4.5M seed round in October 2021 led by Japan Israel High Tech Ventures, with Welltech and Jeremy Coller, according to its release. No later private round was found in sources reviewed on 7 November 2026.
The project budget
How the €3.67M project cost splits
The EU contribution covered 67% of the S-trodes project's recorded cost. The remainder is other project costs, not proof of company cash.
CORDIS, project 190162340. Values in € millions.
What Cannot Be Checked
Questions for the EIC
Whether the sleep system was clinically validated and how it compared with polysomnography, whether a CE application was filed, whether the announced EIC equity investment closed, and why no final periodic report is public are not public.
Why Europe Should Care
Sleep disorders are often unrecognised, the report says, and a validated home test would let far more people be diagnosed. X-trodes has credible technology and leading European sleep scientists as advisers. The EIC grant funded the step from promising patches to a certified sleep test, and the outcome of that step is not on public record.
What the award promised
A clinically validated, CE-marked home sleep test to replace overnight lab studies.
What the record shows
Redesigned patches and algorithms in year one, then no published validation or CE mark.
The Verdict
Half the story told
X-trodes made visible progress in the first year. What happened to the sleep test in the rest of the EIC project has not been made public.
X-trodes and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.
Sources
- CORDIS, S-trodes fact sheet
- CORDIS, S-trodes first periodic report
- FDA 510(k) database, K232210
- PR Newswire, X-trodes FDA clearance, February 2024
- PR Newswire, X-trodes EIC award, June 2023
- Kyodo News PR Wire, X-trodes seed round, October 2021
- CORDIS, S-trodes Results in Brief
- X-trodes, About
- ClinicalTrials.gov, X-trodes accuracy study, NCT05722639
Industry
HealthMedical devices
- Focus
- Respiratory and sleep devices
- Technologies
- Wearable sensors
- Printed electronics
- Electroencephalography
- Keywords
- Home sleep testing
- Sleep medicine
- Polysomnography
- Ambulatory monitoring